Evidence, Value, Access & Pricing
Trinity Value Center of Excellence
End-to-end strategic partnership through a uniquely integrated combination of market access and HEOR expertise
Creating a compelling value narrative that communicates differentiation to multiple stakeholders can mean favorable access and an optimal price point.
The challenge is not just in achieving the holistic, compliant value story and fast coverage recommendations—for many U.S. and global access leaders, it lies in pulling through value communication strategy to value communication tools.
Throughout value work, there are enduring principles that guide value strategy and value communication work:
Trinity’s Value Center of Excellence offers partnership along the value journey to U.S./Global Access and HEOR teams, from strategy to communication.
Trinity approaches value work with a uniquely integrated combination of strategic market access and HEOR expertise.
We create connection and efficiency between HEOR and Access mindsets and needs because we understand and integrate both.
Trinity’s market contextualization is unparalleled in helping clients navigate the commercial environment. Each engagement is built on:
We create value propositions that maximize the impact of evidence and provide effective guidance around evidence gaps and mitigation strategies. Our accurate, HEOR-informed medical writing ensures swift, painless medical and legal review.
Trinity’s Value COE provides end-to-end partnership from early value concepts to value proposition, U.S./global value dossier and objection handlers.
Defining and optimizing payer value must be executed throughout the product lifecycle as the data and market situation evolves. Depending on asset needs, value propositions can be developed at the aspirational/TPP stage and continually updated through final pivotal and real-world data. Trinity Value creates all the tools needed to shape value strategy and communicate value, including:
Briefs
Global Dossiers in the Joint Clinical Assessment Era: Impacts and Implications
Joint clinical assessment (JCA) is a European Union (EU) initiative intended to improve patient access to health technologies in Europe through a harmonized clinical health technology assessment (HTA) process. From January 2025, all new oncology medicines and advanced therapy medicinal products will go through the JCA process, followed by all orphan medicinal products from 2028 […]
Read More
White Papers
Solving a Pervasive Challenge: Breaking Down Silos in Life Sciences
Experts at Trinity Life Sciences interact with the inner workings of pharma from many perspectives as they engage with teams across life sciences organizations. A common observation is that teams are working in silos: often unaware of what other teams are doing, sometimes pulling in different directions and frequently experiencing frustrations. Internally, siloed working can […]
Read More
Webinars
Innovation in Value Strategy: Disrupting the Value Communication Landscape
Available On Demand
Working at the cutting edge of pricing and market access for innovative therapies launched over the last decade, Trinity Life Sciences has seen new diseases, technologies and decision drivers emerge. These have demanded the innovation and testing of new methods and concepts for communicating value to healthcare payers. In this webinar, we will briefly review the core, timeless principles […]
Watch Now
Managing Director &
Head of Value Center of Excellence
Principal,
Evidence, Value, Access & Pricing
Director,
Evidence, Value, Access & Pricing
Partner,
Value, Access & Pricing
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.